Biodexa Pharmaceuticals

BDRXNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.585 M

$1.54 +4.76%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

225,817,808,922

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#497GenprexGNPX$2.16M
#498Matinas BioPharmaMTNB$1.81M
#499China SXT PharmaceuticalsSXTC$1.74M
#500Clearmind MedicineCMND$1.66M
#501Biodexa PharmaceuticalsBDRX$1.58M

Where these numbers come from

Share counts and financials for Biodexa Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.